A spider venom molecule being investigated by a University of Queensland team has met critical benchmarks towards becoming a treatment for heart attack and stroke.
17 January 2024
A company launched from The University of Queensland’s Institute for Molecular Bioscience (IMB) has passed an important milestone in developing an oral treatment for the common skin disease psoriasis.
15 March 2023
Research into global health issues including antibiotic resistance, inflammatory diseases and stroke has been boosted after The University of Queensland received more than $29.7 million in funding from the National Health and Medical Research...
29 August 2019.jpg?itok=mqcCRg-W "Protagonist Therapeutics founder Associate Professor Mark Smythe")
Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
31 October 2016
University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.
22 August 2016
University of Queensland researchers are developing a new asthma treatment that targets the underlying cause of asthma, rather than just the symptoms.
4 May 2015
The University of Queensland has been awarded more than $26 million for health and medical research, to investigate cancer treatments, pain relief, dengue fever vaccinations and more.
18 February 2014
